Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Profit Margin (Quarterly): 9.79% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.79% |
| June 30, 2024 | 11.41% |
| March 31, 2024 | 5.93% |
| December 31, 2023 | 9.29% |
| September 30, 2023 | 7.83% |
| June 30, 2023 | 13.18% |
| March 31, 2023 | 9.65% |
| December 31, 2022 | 10.79% |
| September 30, 2022 | 11.16% |
| June 30, 2022 | 7.60% |
| March 31, 2022 | 3.68% |
| December 31, 2021 | 8.94% |
| September 30, 2021 | 6.19% |
| June 30, 2021 | -1.95% |
| March 31, 2021 | -4.91% |
| December 31, 2020 | 13.26% |
| September 30, 2020 | 22.96% |
| June 30, 2020 | 5.38% |
| March 31, 2020 | 7.39% |
| December 31, 2019 | 11.54% |
| September 30, 2019 | 14.84% |
| June 30, 2019 | -3.56% |
| March 31, 2019 | 8.36% |
| December 31, 2018 | 7.39% |
| September 30, 2018 | 7.75% |
| Date | Value |
|---|---|
| June 30, 2018 | -1.23% |
| March 31, 2018 | 5.09% |
| December 31, 2017 | -2.80% |
| September 30, 2017 | 8.92% |
| June 30, 2017 | 9.55% |
| March 31, 2017 | -22.42% |
| December 31, 2016 | 6.76% |
| September 30, 2016 | 9.00% |
| June 30, 2016 | -4.93% |
| March 31, 2016 | -3.60% |
| December 31, 2015 | -25.47% |
| September 30, 2015 | 5.86% |
| June 30, 2015 | -0.13% |
| March 31, 2015 | -1.29% |
| December 31, 2014 | 6.90% |
| September 30, 2014 | 3.29% |
| June 30, 2014 | -1.63% |
| March 31, 2014 | 4.22% |
| December 31, 2013 | 6.73% |
| September 30, 2013 | 7.02% |
| June 30, 2013 | -3.59% |
| March 31, 2013 | 5.03% |
| December 31, 2012 | 4.00% |
| September 30, 2012 | 3.00% |
| June 30, 2012 | 5.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.91%
Minimum
Mar 2021
22.96%
Maximum
Sep 2020
8.46%
Average
9.12%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Baxter International Inc | 5.19% |
| Globus Medical Inc | 8.28% |
| ResMed Inc | 25.43% |
| Integra Lifesciences Holdings Corp | -2.81% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.51% |
| Return on Assets | 5.40% |
| Return on Invested Capital | 6.54% |
| Gross Profit Margin (Quarterly) | 54.25% |
| Operating Margin (Quarterly) | 14.96% |
| Return on Net Operating Assets | 6.81% |